KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Operating Leases (2019 - 2025)

Historic Operating Leases for Evolent Health (EVH) over the last 7 years, with Q3 2025 value amounting to $22.4 million.

  • Evolent Health's Operating Leases fell 3703.92% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year decrease of 3703.92%. This contributed to the annual value of $25.0 million for FY2024, which is 3430.77% down from last year.
  • As of Q3 2025, Evolent Health's Operating Leases stood at $22.4 million, which was down 3703.92% from $32.6 million recorded in Q2 2025.
  • Evolent Health's Operating Leases' 5-year high stood at $67.8 million during Q1 2021, with a 5-year trough of $22.4 million in Q3 2025.
  • For the 5-year period, Evolent Health's Operating Leases averaged around $50.8 million, with its median value being $56.0 million (2022).
  • In the last 5 years, Evolent Health's Operating Leases crashed by 4120.14% in 2024 and then surged by 1241.45% in 2025.
  • Quarter analysis of 5 years shows Evolent Health's Operating Leases stood at $57.7 million in 2021, then decreased by 2.97% to $56.0 million in 2022, then crashed by 32.14% to $38.0 million in 2023, then tumbled by 34.31% to $25.0 million in 2024, then decreased by 10.39% to $22.4 million in 2025.
  • Its Operating Leases was $22.4 million in Q3 2025, compared to $32.6 million in Q2 2025 and $50.8 million in Q1 2025.